磺脲类与二甲双胍未增加华法林使用者严重出血风险
本研究利用1999-2011年美国5个Medicaid项目的医疗索赔数据,采用自身对照病例系列设计,以华法林为目标药物,计算调整混杂因素后的率比(RR)。在6,463例发生严重出血的华法林使用者中,合并使用格列美脲、格列吡嗪、格列本脲或二甲双胍均与严重出血(胃肠道出血和非创伤性颅内出血的复合结局)发生率升高无关,成分结局GIB或ICH的发生率亦未升高。
要点
- 合并使用磺脲类或二甲双胍未增加华法林使用者严重出血风险。
- 二甲双胍与严重出血风险降低相关(RR: 0.85; 95% CI 0.76-0.96)。
- 格列美脲、格列吡嗪、格列本脲的RR均无统计学显著性。
核心结论
- 华法林使用者合并使用磺脲类或二甲双胍与严重出血发生率升高无关。
研究设计与样本
- 基于1999-2011年美国5个Medicaid项目医疗索赔数据的自身对照病例系列研究,以华法林为目标药物,纳入6,463例发生严重出血的华法林使用者。
主要发现
- 严重出血(GIB和ICH复合结局)与合并使用格列美脲(RR: 0.93; 95% CI 0.75-1.15)、格列吡嗪(RR: 0.97; 95% CI 0.84-1.13)、格列本脲(RR: 0.89; 95% CI 0.76-1.06)或二甲双胍(RR: 0.85; 95% CI 0.76-0.96)均无关。
- 成分结局GIB或ICH的发生率亦未升高。
临床怎么用
- 临床使用华法林时,合并磺脲类或二甲双胍无需因严重出血风险增加而调整抗凝方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug interactions between warfarin and sulfonylureas are suggested by pharmacokinetic information and prior studies. However, clinical evidence on the association of such interactions and the risk of bleeding is lacking. Using healthcare claims data from 5 US Medicaid programs from 1999-2011 and a self-controlled case series design with warfarin as an object drug, we calculated confounder-adjusted rate ratios (RRs) for concomitant use of sulfonylureas and metformin for 3 outcomes separately: (i) serious bleeding as a composite outcome of gastrointestinal bleeding (GIB) and nontraumatic intracranial hemorrhage (ICH); (ii) GIB; and (iii) ICH. In 6,463 warfarin users experiencing serious bleeding, an increased rate of serious bleeding was not associated with concomitant use of glimepiride (RR: 0.93; 95% confidence interval (CI) 0.75-1.15), glipizide (RR: 0.97; 95% CI 0.84-1.13), glyburide (RR: 0.89; 95% CI 0.76-1.06), or metformin (RR: 0.85; 95% CI 0.76-0.96), nor was the occurrence of the component outcomes of GIB or ICH. These results suggest that use of sulfonylureas or metformin was not associated with an increased rate of serious bleeding in warfarin users.
引用
- Nam YH, Han X, Brensinger CM, et al. Sulfonylureas and Metformin Were Not Associated With an Increased Rate of Serious Bleeding in Warfarin Users: A Self-Controlled Case Series Study. Clin Pharmacol Ther. 2020. PMID: 32392373. doi:10.1002/cpt.1885
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。